These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 489194

  • 21. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ, Taylor KP, Ashby MJ, Brown MJ.
    Circulation; 2007 Jul 17; 116(3):268-75. PubMed ID: 17606839
    [Abstract] [Full Text] [Related]

  • 22. Progestogens with antimineralocorticoid activity.
    Losert W, Casals-Stenzel J, Buse M.
    Arzneimittelforschung; 1985 Jul 17; 35(2):459-71. PubMed ID: 4039568
    [Abstract] [Full Text] [Related]

  • 23. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.
    Oelkers W, Berger V, Bolik A, Bähr V, Hazard B, Beier S, Elger W, Heithecker A.
    J Clin Endocrinol Metab; 1991 Oct 17; 73(4):837-42. PubMed ID: 1890155
    [Abstract] [Full Text] [Related]

  • 24. The influence of endogenous mineralocorticoids on the composition of fetal urine.
    Kairaitis K, Lumbers ER.
    J Dev Physiol; 1990 Jun 17; 13(6):347-51. PubMed ID: 2084194
    [Abstract] [Full Text] [Related]

  • 25. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A, Bagdonas G, Yankauskene L, Kazanavichus G.
    Ter Arkh; 2006 Jun 17; 78(2):61-4. PubMed ID: 16613101
    [Abstract] [Full Text] [Related]

  • 26. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C, Weidmann P, de Châtel R, Hirsch D, Reubi FC.
    Schweiz Med Wochenschr; 1977 Jan 29; 107(4):104-15. PubMed ID: 834983
    [Abstract] [Full Text] [Related]

  • 27. [Study of factors affecting the renin-angiotensin-aldosterone system in the premature infant].
    Genova R, Sala R, Frigieri G, Guerra A.
    Pediatr Med Chir; 1982 Jan 29; 4(1-2):49-53. PubMed ID: 7111038
    [Abstract] [Full Text] [Related]

  • 28. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
    Hensen J, Abraham WT, Dürr JA, Schrier RW.
    Am J Nephrol; 1991 Jan 29; 11(6):441-6. PubMed ID: 1840232
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Aldosterone antagonism studies in the rhesus monkey.
    Hofmann LM, Pedrera HA, Suleymamov OD.
    J Pharmacol Exp Ther; 1977 Jul 29; 202(1):216-20. PubMed ID: 406381
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Aldosterone response to prolonged ACTH infusion in juvenile hypertension.
    Rauh W, Gottesdiener K, Chow D, Forster E, Saenger P, Levine LS, New MI.
    Pediatr Res; 1980 Sep 29; 14(9):1035-9. PubMed ID: 6256713
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of spironolactone and its main metabolite canrenone on the renin-angiotensin-aldosterone-system during long-term treatment in rats.
    Erbler HC.
    Acta Endocrinol (Copenh); 1979 Jan 29; 90(1):147-56. PubMed ID: 760354
    [No Abstract] [Full Text] [Related]

  • 36. Dose-response relationships for spironolactone at steady state.
    McInnes GT, Perkins RM, Shelton JR, Harrison IR.
    Clin Pharmacol Ther; 1982 Mar 29; 31(3):317-23. PubMed ID: 7060315
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Does spironolactone use at arterial hypertension therapy protect endothelium also in smoking patients?].
    Kara-Perz H, Kosicka T, Perz S.
    Przegl Lek; 2009 Mar 29; 66(10):571-3. PubMed ID: 20301883
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.